Submissions from 2020
Anifrolumab in systemic lupus erythematosus: Current knowledge and future considerations, E. Anderson and R. Furie
The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm., A. S. Chau, A. G. Weber, N. I. Maria, S. Narain, A. Liu, N. Hajizadeh, P. Malhotra, O. Bloom, G. Marder, and B. Kaplan
Using the Mouse to Model Human Diseases: Cognitive Impairment in Systemic Lupus Erythematosus, L. E. Khoury, A. Zarfeshani, and B. Diamond
Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm., S. Narain, D. G. Stefanov, A. S. Chau, A. G. Weber, G. Marder, B. Kaplan, P. Malhotra, O. Bloom, A. Liu, M. M. Lesser, N. Hajizadeh, and Northwell COVID-19 Research Consortium
Submissions from 2019
A case of dolutegravir-induced cutaneous small vessel vasculitis, B. S. Bennett, N. Mikaberidze, and L. M. Ahmadi
Submissions from 2018
Lessons learned from bone marrow failure in systemic lupus erythematosus: Case reports and review of the literature, E. Anderson, B. Shah, A. Davidson, and R. Furie
TUBERCULOUS CHOROIDITIS IN PATIENT WITH VOGT-KOYANAGI-HARADA DISEASE., E. W. Anderson, L. El Khoury, J. S. Schwartzman-Morris, J. Jonisch, and N. R. Goldberg
Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting., J. C. Berkowitz, J. Stein-Fishbein, S. Khan, R. Furie, and K. S. Sultan